Differential Phenotypes in Perivascular Adipose Tissue Surrounding the Internal Thoracic Artery and Diseased Coronary Artery.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
22 01 2019
Historique:
entrez: 15 1 2019
pubmed: 15 1 2019
medline: 4 1 2020
Statut: ppublish

Résumé

Background Perivascular adipose tissue ( PVAT ) is causally associated with vascular function and the pathogenesis of vascular disease in association with metabolically driven chronic inflammation called metaflammation. However, the difference in PVAT surrounding the coronary artery ( CA - PVAT ) and that surrounding the internal thoracic artery (ITA-PVAT), a vessel resistant to atherosclerosis, remains unclear. Herein, we investigated whether CA - PVAT , ITA - PVAT , and subcutaneous adipose tissue ( SCAT ) have distinct phenotypes. Methods and Results Fat pads were sampled from 44 patients (men/women, 36:8; age, 67±13 years) with CA disease who underwent elective CA bypass grafting. Adipocyte size in ITA - PVAT and that in CA - PVAT were significantly smaller than that in SCAT . A greater extent of fibrosis and increased gene expression levels of fibrosis-related molecules were observed in CA - PVAT than those in SCAT and those in ITA - PVAT . CA - PVAT exhibited more pronounced metaflammation, as indicated by a significantly larger extent of CD 68-positive and CD 11c-positive M1 macrophages, a lower ratio of CD 206-positive M2 to CD 11c-positive M1 macrophages, a lower gene expression level of adiponectin, and higher gene expression levels of inflammatory cytokines and inflammasome- and endoplasmic reticulum stress-related molecules, than did ITA - PVAT and SCAT . Expression patterns of adipocyte developmental and pattern-forming genes were totally different among SCAT , ITA - PVAT, and CA - PVAT . Conclusions The phenotype of ITA - PVAT is closer to that of SCAT than that of CA - PVAT , which may result from inherent differences in adipocytes. ITA - PVAT appears to be protected from metaflammation and consecutive adipose tissue remodeling, which may contribute to the decreased atherosclerotic plaque burden in the ITA.

Identifiants

pubmed: 30638109
doi: 10.1161/JAHA.118.011147
pmc: PMC6497339
doi:

Substances chimiques

Angiogenic Proteins 0
Biomarkers 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e011147

Références

Annu Rev Immunol. 2011;29:415-45
pubmed: 21219177
J Atheroscler Thromb. 2017 May 1;24(5):443-451
pubmed: 28260724
Clin Res Cardiol. 2016 Nov;105(11):887-900
pubmed: 27337945
J Clin Invest. 2006 Jul;116(7):1784-92
pubmed: 16823476
Clin Sci (Lond). 2012 Jan;122(1):1-12
pubmed: 21910690
Circ J. 2011;75(4):766-72
pubmed: 21415547
Sci Rep. 2014 Nov 06;4:6943
pubmed: 25373918
J Pathol. 1998 May;185(1):4-9
pubmed: 9713353
Circulation. 2003 Nov 18;108(20):2460-6
pubmed: 14581396
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1738-1747
pubmed: 29954752
Eur Heart J. 2003 Feb;24(4):329-36
pubmed: 12581680
Diabetes. 2010 Jul;59(7):1648-56
pubmed: 20357360
Circ Res. 2009 Feb 27;104(4):541-9
pubmed: 19122178
Scan Electron Microsc. 1981;(Pt 2):275-80
pubmed: 7034168
Arterioscler Thromb Vasc Biol. 2009 May;29(5):781-6
pubmed: 19229071
J Am Heart Assoc. 2017 Sep 13;6(9):
pubmed: 28903937
Nat Commun. 2014 Sep 19;5:4982
pubmed: 25236782
Diabetes. 2011 Mar;60(3):819-26
pubmed: 21282371
Am J Physiol Heart Circ Physiol. 2014 May;306(9):H1314-23
pubmed: 24610918
Am Heart J. 2007 Jun;153(6):907-17
pubmed: 17540190
Cell. 2010 Mar 19;140(6):900-17
pubmed: 20303879
Diabetes. 2010 Nov;59(11):2817-25
pubmed: 20713683
J Clin Invest. 2007 Jan;117(1):175-84
pubmed: 17200717
Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6676-81
pubmed: 16617105
Arterioscler Thromb Vasc Biol. 2016 May;36(5):825-34
pubmed: 27013610
J Clin Invest. 2011 Jun;121(6):2094-101
pubmed: 21633177
J Lipid Res. 2005 Nov;46(11):2347-55
pubmed: 16150820
J Thorac Cardiovasc Surg. 1990 Apr;99(4):703-7
pubmed: 2319794
Adipocyte. 2018;7(3):156-165
pubmed: 29956579
PLoS One. 2013 Nov 11;8(11):e79245
pubmed: 24244459
J Clin Invest. 2007 Sep;117(9):2362-8
pubmed: 17786229
Arch Pathol Lab Med. 2007 Mar;131(3):481-7
pubmed: 17516753
Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E298-307
pubmed: 16985259
J Thorac Cardiovasc Surg. 2016 Jun;151(6):1704-8
pubmed: 26971376
Ann Cardiothorac Surg. 2013 Jul;2(4):519-26
pubmed: 23977631
Life Sci. 2013 Dec 18;93(25-26):1023-32
pubmed: 24200844
Nat Immunol. 2012 Mar 19;13(4):352-7
pubmed: 22430788
Mol Cell Biol. 2009 Aug;29(16):4467-83
pubmed: 19546236
Arterioscler Thromb Vasc Biol. 2013 May;33(5):1077-84
pubmed: 23471228
Nature. 2017 Feb 8;542(7640):177-185
pubmed: 28179656
Physiol Genomics. 2013 Aug 15;45(16):697-709
pubmed: 23737535
Curr Vasc Pharmacol. 2014 Jan;12(1):144-51
pubmed: 22724466
Diabetologia. 2012 May;55(5):1514-25
pubmed: 22327346
Immunity. 2015 Jun 16;42(6):1100-15
pubmed: 26084025
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):880-891
pubmed: 29496660
J Am Coll Cardiol. 2018 Jan 30;71(4):414-425
pubmed: 29389358
Mol Cell Biol. 2009 Mar;29(6):1575-91
pubmed: 19114551
Circulation. 2013 Jul 2;128(1):9-18
pubmed: 23685742
J Am Heart Assoc. 2019 Jan 22;8(2):e011147
pubmed: 30638109
Atheroscler Suppl. 2017 Nov;30:149-158
pubmed: 29096831
Nat Rev Drug Discov. 2016 Sep;15(9):639-660
pubmed: 27256476
Am Heart J. 1983 Apr;105(4):560-6
pubmed: 6837411

Auteurs

Ryosuke Numaguchi (R)

1 Department of Cardiovascular Surgery Sapporo Medical University School of Medicine Sapporo Japan.

Masato Furuhashi (M)

2 Department of Cardiovascular, Renal and Metabolic Medicine Sapporo Medical University School of Medicine Sapporo Japan.

Megumi Matsumoto (M)

2 Department of Cardiovascular, Renal and Metabolic Medicine Sapporo Medical University School of Medicine Sapporo Japan.

Hiroshi Sato (H)

1 Department of Cardiovascular Surgery Sapporo Medical University School of Medicine Sapporo Japan.

Yosuke Yanase (Y)

1 Department of Cardiovascular Surgery Sapporo Medical University School of Medicine Sapporo Japan.

Yosuke Kuroda (Y)

1 Department of Cardiovascular Surgery Sapporo Medical University School of Medicine Sapporo Japan.

Ryo Harada (R)

1 Department of Cardiovascular Surgery Sapporo Medical University School of Medicine Sapporo Japan.

Toshiro Ito (T)

1 Department of Cardiovascular Surgery Sapporo Medical University School of Medicine Sapporo Japan.

Yukimura Higashiura (Y)

2 Department of Cardiovascular, Renal and Metabolic Medicine Sapporo Medical University School of Medicine Sapporo Japan.

Masayuki Koyama (M)

2 Department of Cardiovascular, Renal and Metabolic Medicine Sapporo Medical University School of Medicine Sapporo Japan.

Marenao Tanaka (M)

2 Department of Cardiovascular, Renal and Metabolic Medicine Sapporo Medical University School of Medicine Sapporo Japan.

Norihito Moniwa (N)

2 Department of Cardiovascular, Renal and Metabolic Medicine Sapporo Medical University School of Medicine Sapporo Japan.

Masanori Nakamura (M)

3 Department of Cardiovascular Surgery Sapporo City General Hospital Sapporo Japan.

Hirosato Doi (H)

1 Department of Cardiovascular Surgery Sapporo Medical University School of Medicine Sapporo Japan.
4 Department of Cardiovascular Surgery Sapporo Cardiovascular Clinic Sapporo Japan.

Tetsuji Miura (T)

2 Department of Cardiovascular, Renal and Metabolic Medicine Sapporo Medical University School of Medicine Sapporo Japan.

Nobuyoshi Kawaharada (N)

1 Department of Cardiovascular Surgery Sapporo Medical University School of Medicine Sapporo Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH